Clinical trials
MG clinical trials
Below are recruiting mg clinical trials, each written for real people, not researchers. We’re tracking 936 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06303128RecruitingPhase 3
Testing penicillin allergy with one vs. two oral doses
This trial compares a single dose versus two doses of a penicillin-like drug to see if people who think they are allergic to penicillin can safely be told they are not allergic. It is for people with a low-risk penicillin allergy who want to find out if they can use these antibiotics in the future.
Lubbock, TexasAges 18–89 - NCT07142291RecruitingPhase 2
Cromolyn inhaler for early ALS
This trial tests if an inhaled drug called cromolyn can help people with early-stage ALS. It is for people who can still breathe well and are not yet using a ventilator.
Scottsdale, ArizonaAges 18–75 - NCT07140328RecruitingPhase 2
Testing a new inhaler for COPD symptoms
This trial tests two forms of a new medication (HSK39004) in people with COPD. The goal is to see if they help improve breathing and are safe. Eligible participants must be between 40 and 80, have moderate to severe COPD, and be able to stop other COPD treatments during the study.
Nanchang, JiangsuAges 40–80 - NCT05788094RecruitingPhase 4
Compare two medicines for P. vivax malaria
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
Mae Sot, Changwat TakAges 18 years+ - NCT07082114RecruitingPhase 3
Testing a new tablet for type 2 diabetes
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
Yueyang, HunanAges 18–75 - NCT06509893RecruitingPhase 4
Ticagrelor alone after stent placement
This study tests if a single blood thinner (ticagrelor) works well enough after getting a heart stent, instead of the usual two blood thinners. It may simplify your daily medication routine.
Shiraz, FarsAges 20–80 - NCT07072195RecruitingPhase 2
A study of AMC6156 for people with muscle loss
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
Seongnam-si, Gyeonggi-doAges 65 years+ - NCT07053319RecruitingPhase 1
Study of diabetes drugs and ketones
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
San Antonio, TexasAges 30–75 - NCT07016269RecruitingPhase 4
Study of CnU Cap. 500 mg for Biliary Dyspepsia
This trial tests a medication called CnU Cap. 500 mg to see if it helps people with biliary dyspepsia, a type of upper belly pain caused by the gallbladder or bile ducts. It may help if you have episodes of steady pain in the upper right belly that last at least 30 minutes and disrupt your daily life.
Ansan, Gyeonggi-doAges 19 years+ - NCT05513365RecruitingPhase 2
Dutasteride added to anti-androgen treatment for salivary cancer
This Phase 2 trial studies whether adding dutasteride to standard anti-androgen therapy can shrink or slow an advanced salivary gland cancer. It is for cancers that test “androgen receptor (AR) positive,” meaning they may respond to medicines that block male-hormone signals.
Nijmegen, GelderlandAges 18 years+ - NCT06977594Recruiting
Preventing allergic reactions during chemo for gynecologic cancer
This study tests a proactive approach to reduce allergic reactions to common chemotherapy drugs (paclitaxel and carboplatin) used for gynecologic cancers. It aims to make treatment safer and more comfortable for patients.
SeoulAges 19 years+ - NCT06967753RecruitingPhase 4
Switching to a two-drug HIV regimen for transgender women
This trial tests if switching to a two-drug combination of dolutegravir and lamivudine is safe and effective for transgender women who already have undetectable HIV levels on a three-drug regimen. It aims to simplify treatment and reduce side effects.
Buenos Aires, Buenos Aires F.D.Ages 18 years+ - NCT06972056RecruitingPhase 4
Comparing migraine prevention drugs: atogepant, propranolol, topiramate
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
Flagstaff, ArizonaAges 18–70 - NCT06953986Recruiting
Comparing three medicines for severe acid reflux healing
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
Hyderabad, TelanganaAges 18–75 - NCT06917963Recruiting
Preventing high stoma output with omeprazole
This trial tests if a stronger dose of omeprazole can help prevent high fluid output from a new ileostomy (a surgically created opening in the belly that passes waste). If you are scheduled for surgery to create an ileostomy, you may be able to join.
Gdansk, Pomeranian VoivodeshipAges 18 years+ - NCT05692999RecruitingPhase 3
Maintenance pembrolizumab dose study for non-squamous lung cancer
This Phase 3 trial tests two maintenance schedules (“usual” dose versus a lower dose) of pembrolizumab after your initial chemotherapy with pembrolizumab. It aims to see if the lower dose works well enough to control cancer while possibly reducing side effects.
NamurAges 18 years+ - NCT06859710RecruitingPhase 1
THC and CBD as a harm reduction strategy
This study looks at whether different types of cannabis (containing THC and/or CBD) might help people who use cannabis regularly reduce potential harms. You will be asked to take cannabis in a controlled setting and complete tasks and questionnaires.
Los Angeles, CaliforniaAges 21–55 - NCT06813651RecruitingPhase 2
TBO-309 for stroke with tandem blockage
This trial tests whether adding TBO-309 to standard treatment helps people having a stroke caused by two blockages (one in the neck, one in the brain). It may limit brain damage and improve recovery.
Newcastle, New South WalesAges 18 years+ - NCT06803030RecruitingPhase 3
Study of three drugs for ureteral stent discomfort
This trial is testing three different medicines to see if they can reduce common symptoms like pain and frequent urination caused by a ureteral stent placed after kidney stone surgery. If you are between 19 and 80 years old and had a stent placed during ureteroscopy, you may be able to join.
Kathmandu, BagmatiAges 18–80 - NCT06034938RecruitingPhase 2
Switching HIV Meds for People With M184V Mutation
This study tests switching your current HIV medicines to a once-daily pill combining doravirine, tenofovir, and lamivudine, specifically for people whose virus has a past M184V mutation but is now well controlled.
CaenAges 18 years+ - NCT06767800RecruitingPhase 2
Study of TQB2102 with immunotherapy for HER2-positive gastroesophageal cancer
This trial tests a new combination of drugs (TQB2102, benmelstobart, and pembrolizumab) with or without chemotherapy for people with HER2-positive gastroesophageal cancer that cannot be removed by surgery or has spread. It aims to see if this combination is more effective than current treatments.
Fuyang, AnhuiAges 18–75 - NCT06687551RecruitingPhase 4
Testing lower doses of JAK inhibitors for rheumatoid arthritis
This study tests whether people with rheumatoid arthritis whose disease is well controlled can safely take a lower dose of their JAK inhibitor medication. It aims to see if reducing the dose still keeps inflammation down and prevents flare-ups.
Toulouse, OccitanieAges 18–65 - NCT06671054RecruitingPhase 2
Testing AP1189 for newly diagnosed active rheumatoid arthritis
This study tests an oral drug called AP1189 for people just diagnosed with active rheumatoid arthritis who haven't yet taken standard arthritis medicines. You may be able to take part if your disease is very active and you're ready to try a new treatment option.
Cutler Bay, FloridaAges 18 years+ - NCT06643221RecruitingEarly Phase 1
Exercise as a booster for cell therapy treatments
This trial tests whether exercise and a heart medicine called isoproterenol can help your immune system work better with donor cell therapies. It may show how to make these treatments more effective.
Tucson, ArizonaAges 21–55
Hear when a new MG trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for mg?
- Yes. Clin2 currently lists 936 recruiting mg studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a mg trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a mg trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.